United Therapeutics | UTHR - Stammkapital

Aktienkurs
567.16
Täglich Wechseln
-5.69 -0.99%
Monatlich
4.72%
Jährlich
94.65%
Q2 Prognose
555.02




Stammkapital Veränderung Datum
Amarin USD 20.81M 13K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Bayer EUR 982.42M 0 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
Insmed USD 214.26M 1.67M 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
J&J USD 2.41B 1.74M 2025-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Moderna USD 391M 2M 2025-09
Omeros USD 611K 17K 2023-12
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.96M 196K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
United Therapeutics USD 43.64M 740K 2025-12
Vertex Pharmaceuticals USD 254M 0 2025-12